Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	247–260
Cyfnodolyn	International Journal of Research in Marketing
Cyfrol	25
Rhif cyhoeddi	4
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1016/j.ijresmar.2008.08.002
Statws	Cyhoeddwyd - 1 Rhag 2008

Mynediad at Ddogfen

@article{dba040b9a6914844bdd4104c31c57e6d,

title = "Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.",

author = "J. Gonzalez and P. Stern and S. Dutta and C. Sismero",

year = "2008",

month = dec,

day = "1",

doi = "10.1016/j.ijresmar.2008.08.002",

language = "English",

volume = "25",

pages = "247–260",

journal = "International Journal of Research in Marketing",

issn = "0167-8116",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.

AU - Gonzalez, J.

AU - Stern, P.

AU - Dutta, S.

AU - Sismero, C.

PY - 2008/12/1

Y1 - 2008/12/1

U2 - 10.1016/j.ijresmar.2008.08.002

DO - 10.1016/j.ijresmar.2008.08.002

M3 - Article

SN - 0167-8116

VL - 25

SP - 247

EP - 260

JO - International Journal of Research in Marketing

JF - International Journal of Research in Marketing

IS - 4

ER -